Rastislav Jendzelovsky (Rastislav Jendželovský)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 8

Top Venues

Cancers

International journal of molecular sciences

Molecules (Basel, Switzerland)

Life (Basel, Switzerland)

P. J. Šafárik University in Košice

This page only lists publications with an associated author ORCID identifier.

Affiliation History

P. J. Šafárik University in Košice

Slovakia

postdoc :: Department of cellular biology, Institute of Biology and Ecology

Publications

Nicol Urbanska, Patrik Simko, Andrea Leskanicova, Martina Karasová, Zuzana Jendzelovska, Rastislav Jendzelovsky, Dajana Rucova, Mariana Kolesarova, Michal Goga, Martin Backor, Terezia Kiskova
Atranorin, a Secondary Metabolite of Lichens, Exhibited Anxiolytic/Antidepressant Activity in Wistar Rats. Life (Basel, Switzerland) 12 (11) (2022)
Martin Majerník, Rastislav Jendzelovsky, Jana Vargová, Zuzana Jendželovská, Peter Fedoročko
Multifunctional Nanoplatforms as a Novel Effective Approach in Photodynamic Therapy and Chemotherapy, to Overcome Multidrug Resistance in Cancer. Pharmaceutics 14 (5) (2022)
Mária Vilková, Monika Hudáčová, Nikola Palušeková, Rastislav Jendzelovsky, Miroslav Almáši, Tibor Béres, Peter Fedoročko, Maria Kozurkova
Acridine Based N -Acylhydrazone Derivatives as Potential Anticancer Agents: Synthesis, Characterization and ctDNA/HSA Spectroscopic Binding Properties. Molecules (Basel, Switzerland) 27 (9) (2022)
Monika Hudáčová, Slavka Hamulakova, Eva Žilecká, Rastislav Jendzelovsky, Jana Vargová, Juraj Ševc, Peter Fedoročko, Ondrej Soukup, Jana Janočková, Veronika Ihnatova, Tomas Kucera, Petr Bzonek, Nikola Novakova, Daniel Jun, Lucie Junova, Jan Korabecny, Teodorico C Ramalho, Maria Kozurkova
Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells. International journal of molecular sciences 22 (8) (2021)
Marián Babinčák, Rastislav Jendzelovsky, Ján Košuth, Martin Majerník, Jana Vargová, Kamil Mikulášek, Zbyněk Zdráhal, Peter Fedoročko
Death Receptor 5 (TNFRSF10B) Is Upregulated and TRAIL Resistance Is Reversed in Hypoxia and Normoxia in Colorectal Cancer Cell Lines after Treatment with Skyrin, the Active Metabolite of Hypericum spp. Cancers 13 (7) (2021)
Eva Konkoľová, Monika Hudáčová, Slávka Hamuľaková, Rastislav Jendzelovsky, Jana Vargová, Juraj Ševc, Peter Fedoročko, Maria Kozurkova
Tacrine-Coumarin Derivatives as Topoisomerase Inhibitors with Antitumor Effects on A549 Human Lung Carcinoma Cancer Cell Lines. Molecules (Basel, Switzerland) 26 (4) (2021)
Martin Majerník, Rastislav Jendzelovsky, Peter Fedoročko
Potentiality, Limitations, and Consequences of Different Experimental Models to Improve Photodynamic Therapy for Cancer Treatment in Relation to Antiangiogenic Mechanism. Cancers 12 (8) (2020)
Martin Majerník, Rastislav Jendzelovsky, Marián Babinčák, Ján Košuth, Juraj Ševc, Zuzana Tonelli Gombalová, Zuzana Jendželovská, Monika Buríková, Peter Fedoročko
Novel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane. International journal of molecular sciences 20 (12) (2019)

Rastislav Jendzelovsky.css-eqlu8i{font-size:small;padding-left:4px;} (Rastislav Jendželovský)

Publication Activity (10 Years)

Top Topics

Top Venues

Rastislav Jendzelovsky (Rastislav Jendželovský)